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Cancer continues to take many lives each year and has posed a seemingly 
insurmountable challenge to scientists around the world. Traditional methods of 
treatment, including chemotherapy, are ineffective and result in undesirable effects on 
healthy tissue. As a result, researchers are seeking new methods of targeted therapy that 
will kill only tumor cells. Stemming from the discovery of the Enhanced Permeability 
and Retention (EPR) effect and recent advances in nanotechnology, one such method 
involves the use of nanoparticles as drug carriers into the core tumor tissue by taking 
advantage of characteristic features of the tumor vasculature.  Although this method has 
shown promise in inducing targeted effects, effective distribution of these particles in 
vivo are inhibited by a host of factors, including the dense collagen matrix that makes up 
tumors. Furthermore, the failure of animal model study results to translate into positive 
outcomes in human trials has warranted the need for new testing methods that model the 
in vivo tumor conditions seen in patients. This study aims to address both these issues by 
developing a basis of experiments that can be utilized for the development of a collagen-








Each year, approximately 8 million individuals around the world die of cancer [1]. 
Despite the many advancements in technology and medicine in recent decades, traditional 
methods of treatment, such as surgery and chemotherapy, continue to fail to provide 
consistent efficacies for treating patients. This motivated the field to develop and test new 
methods of targeted treatment. The goals of these new techniques are focused on drug 
delivery to the tumor tissue, ensuring only tumor cells are targeted by the medicine. 
Emerging discoveries on the architecture of the tumor microenvironment have provided 
new avenues by which to deliver drugs. Furthermore, recent advancements in 
nanotechnology have allowed scientists and engineers to begin using a tumor’s physical 
properties as an alternate method of targeted drug delivery.  
The foundations for the use of this method of targeted treatment began with the 
understanding of the enhanced permeability and retention (EPR) effect in tumors. Early 
research of this physical phenomenon began in the 1980s. In 1986, Matsumura and 
Maeda found that the poorly-developed tumor vasculature resulted in “leaky” blood 
vessels [2]. As a result, molecules falling within a specific size range extravasated into 
the tumor microenvironment. After this initial discovery, nanoparticle-based drug carriers 
were developed to exploit this phenomenon. Over the course of the next 25 years, 
researchers have continued to work with these nanoparticles to develop a fine-tuned drug 
delivery system that targets only tumor cells.  
Although a great amount of research has been dedicated to the development of 
these new drug-carrying particles, scientists have faced many challenges in testing these 
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molecules for their efficacy in vivo. Most studies utilize animal models in which mice are 
artificially induced to develop tumors and subsequently injected with various 
concentrations of nanoparticles. Researchers then use in vivo imaging and other 
techniques to measure the effectiveness of the particles in slowing down tumor growth. 
Although there are variations in the drug delivery system, such as ones in which the 
particles change size upon reaching the tumor [3] or a communicating system of 
nanoparticles that locates the tumor and attacks it [4], researchers struggle to reproduce 
the positive results seen in these mice models during clinical trials in humans. One 
possible explanation for this discrepancy is the use of mice for validation, models that do 
not capture all the inherent features of the human body. As a result, a new cohort of 
researchers is looking into methods of testing that replicate the in vivo conditions of solid 
human tumors. For example, researchers have begun developing a microfluidic device 
that mimics the fluid flow seen in the tumor vasculature [5]. This device could then be 
used to test the nanoparticles that other researchers develop.  
This study seeks to lay the foundation for the development of a collagen-based 
model that not only mimics the fiber structure within the tumor microenvironment, but 
that also can be used to test the diffusion of nanoparticles through this space. This model 
would be in the form of a microfluidic device that consists of flow channels and an inner 
core chamber that contains collagen. Flow channel dimensions would be modeled after 
the blood vessels seen in the tumor microenvironment. Because it is known that tumors 
have a dense collagen network [6], establishing a method to create collagen gels that are 
similar to what is seen in tumors will allow for the use of a model that is comparable to 
the human body. Furthermore, studies have identified that the dense collagen networks 
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act as one of the primary barriers for nanoparticles [7]. As a result, efficacy of the drugs 
is significantly decreased due to the low concentration of therapeutic reaching the tumor. 
By creating this collagen-based model, this study will provide other researchers in this 
field an alternate method of testing; one that is not only cheaper than animal-based 




















The search to develop targeted treatment methods for cancer has opened my 
avenues by which to deliver drugs. One such method takes advantage of the physical 
properties inherent to the vasculature of tumors as a method of drug delivery. Despite 
how promising this technique has been to shown to be, more studies are needed to 
develop a more efficient model that cannot only be used to test this approach, but also 
ensure it simulates the physiological properties seen in the tumor tissue.  
EPR Effect and the Use of Nanoparticles 
 Early research in this field began with work that sought to understand the 
underlying properties of the tumor microenvironment. The most significant discovery 
that emerged from this focus area was the identification of the EPR (Enhanced 
Permeability and Retention) effect. Research found that certain proteins accumulated in 
the tumor tissue space. This was in large part due to the vasculature of most solid tumors, 
largely comprised of leaky blood vessels [2]. Further research found that only molecules 
of certain sizes possessed the ability to extravasate into the tumor microenvironment [8]. 
As a result, these molecules accumulate in higher concentrations. This special form of 
accumulation posed the possibility of its use for targeted drug delivery. Therefore, these 
findings lead researchers to develop new technology that could take advantage of this 
research. 
With the identification of the EPR effect, researchers began to see the 
advantageous use of this physiological phenomenon for targeted drug delivery. Because 
of advances in nanotechnology, scientists began to develop drug carriers that fell within 
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the given size range dictated by the findings of the EPR theory. These new molecules 
came in many shapes and forms. Some were hydrogel particles, liposomes or even carbon 
nanotubes [9]. Studies using this wide variety of molecules showed that different 
particles could be tuned to have specific properties. However, researchers began to face a 
host of challenges in the use of these nanoparticles (NPs).  
Challenges with Current Methods 
As more researchers began utilizing nanoparticles as a means of inhibiting tumor 
growth, they began to face some challenges in using this developing technology. One of 
the most common problems faced by scientists was in ensuring proper targeting of these 
molecules and enhancing deeper tissue penetration. Initially, most individuals were 
injecting these particles directly into the bloodstream, with the hopes that a reasonable 
proportion of these NPs would reach the tumor microenvironment due to the size-
selectivity of the EPR effect [8]. However, researchers were seeing that a low 
concentration of these particles was reaching the tumor. Furthermore, even if the 
molecules did reach the tumor, the NPs were unable to penetrate deeply into the tumor 
tissue. Studies attempted to circumvent these problems by developing nanoparticle 
systems that increased the likelihood of these molecules reaching the tumor. For example, 
particles were created to shrink in size upon entering the tumor microenvironment. This 
structural change was triggered by proteins specific to the tumor tissue [3]. Others used 
the knowledge of lower pH in tumors to create molecules that were pH-sensitive. Once 
the NPs entered the tumor and sensed the change in pH, they shrunk to an appropriate 
size that would allow for their uptake into the tumor vasculature [10]. Although these 
studies showed the potential of using these methods of drug delivery, they were still 
 6 
unable to ensure deep penetration into the tumor space, an area when left untreated has 
precludes complete elimination of tumor cells.  
One key aspect that many of these studies failed to address is the tissue 
architecture of the tumor environment. Many of these studies did not account for the 
physical barriers for NP movement inside the tumor. One of the major obstacles that the 
NPs face in reaching the tumor microenvironment is the dense collagen that makes up the 
tumor tissue [6]. It is believed that the collagen hinders the diffusion of the nanoparticles 
inside the body [7].  Despite these findings that highlight the obstructive role of collagen, 
few studies have looked into understanding how the collagen affects the diffusion of NPs.  
Nanoparticle Drug Testing 
While testing nanoparticles as drug carries for attacking tumors has shown to be 
promising, researchers also face the challenge of appropriate methods of testing. 
Currently, validation of these emerging techniques are conducted in murine models. 
However, doubts on the effectiveness of using this method of testing have been raised as 
a result of the failure of these technologies to replicate the positive results seen in mice 
when carried to human clinical trials. Researchers have begun to point out that xenograft 
models fail to predict human outcomes because of the “largely unknown factors of 
extrapolation” [5]. Therefore, this warrants the need for the development of new models 
that mimic that the physiological conditions seen in the human body. A few recent 
studies have worked on developing organs on a chip.  Among these studies, some 
researchers have focused their efforts on developing a “tumor on a chip” [5]. This process 
involves the development of a microfluidic device that comprises of components that are 
similar to those that make up the tumor microenvironment. For example, it includes 
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specific channels similar to the lymphatic vessels or the blood vessels that feed into the 
core of the chip, which models the tumor. This device can then be used to test diffusion 
of nanoparticles under different conditions. A key feature of the tumor component 
involves the use of collagen. Although the researchers attempted to mimic the collagen 
network found in tumors in vivo, more knowledge is needed in developing an accurate 
collagen component. 
This study aims to address this challenge associated with the use of NPs by 
developing a collagen-based model that will provide for an effective method of testing. 
Because it is known that the collagen network found in tumors obstructs the movement of 
these particles in this microenvironment, a smaller concentration of the molecules reaches 
the tumor. As a result, the efficacy of the drug is reduced. This study will develop a 
collagen model that is based on the physical properties of the collagen network in tumor 
tissues, specifically through the development of a microfluidic device. This device could 
then be used to study the diffusion of NPs through the fibers and, as a result, provide a 
better understanding on how the collagen affects the movement of particles. By 
developing a collagen model that mimics the tumor environment found inside the body, 
this study will provide not only a method for testing but also gather knowledge that could 





MATERIALS AND METHODS 
 Two protocols were established for the creation of the collagen gels. One protocol 
was used for making gels of higher density (i.e. concentration >=3 mg/mL) and other 
protocol for gels of lower density (i.e. concentration <= 3 mg/mL). Having these two 
distinct protocols allowed for greater flexibility in the types of gels for subsequent 
experiments. 
Collagen Gels: High-Density 
 
Materials 
 High-density Rat-tail, Collagen, Type I solution (Concentration = 8.6 mg/ml) 
 0.17M EDTA 
 0.1M NaOH 
 Bucket of ice 
 Tube of sufficient volume 
 Ultrapure H2O 
Method 
1) Placed collagen rat tail solution, 10x PBS (+/+), ultrapure H2O, 0.1M NaOH and 
0.17 EDTA on ice for 10 minutes 
2) Added 141.78 µL of collagen rat tail solution to a tube of sufficient volume. 
3) Added 19.5 µL of 0.17M EDTA 
4) Added 3.8 µL of 0.1M NaOH 
5) Added appropriate amount of H2O needed for concentration of gel required 
6) Swirled tube to mix. Vortexed tube for 10 seconds 
7) Incubated for at least 24 hours at 37ºC and 5% CO2  
 
Gels of 3 different concentrations (3 mg/mL, 5mg/mL and 7 mg/mL) were made. Table 1 




3 mg/mL 5mg/mL 7 mg/mL 
141.78 µL of collagen stock 141.78 µL of collagen stock 141.78 µL of collagen stock 
19.5 µL of 0.17M EDTA 19.5 µL of 0.17M EDTA 19.5 µL of 0.17M EDTA 
3.8 µL of 0.1M NaOH 3.8 µL of 0.1M NaOH 3.8 µL of 0.1M NaOH 
241.3 µL of  H2O 78.8 µL of  H2O No water 
Table 1: Volume of reagents needed for various concentrations of gels 
 
Collagen Gels: Low-Density 
 
Materials 
 Rat-tail, Collagen, Type I solution (Concentration = 3 mg/ml) 
 10x PBS (+/+) 
 0.1M NaOH 
 Bucket of ice 
 Tube of sufficient volume 
 pH strips 
 Ultrapure H2O 
 
Method 
8) Placed collagen rat tail solution, 10x PBS (+/+), ultrapure H2O and 0.1M NaOH 
on ice for 10 minutes 
9) Added starting volume of collagen rat tail solution to a tube of sufficient volume. 
10) Added a volume of PBS that is equal to 1/9th of the starting volume of the 
collagen solution.  
11) Swirled tube to mix. (NOTE: DID NOT VORTEX) 
12) Used 0.1M NaOH and pH strips to bring collagen gels solution to a final pH of 
~7.4. 
a. Swirled tube to mix solution after each addition of NaOH. Leave solution 
in ice during this process 
13) Determined the final concentration of the collagen gel solution 
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a. NOTE: Final concentration was at least 1.5 mg/mL. 
b. If final concentration needed to be adjusted, required volume of ultrapure 
H2O was added. 
14) Pipetted gel solution into a 12-well plate. Incubate for 1hr at 37°C, 5% CO2 
Confocal Imaging 
 
2-photon imaging was used to obtain images of the fibers in the collagen. This 
imaging step served two purposes: 1) Confirm that the gels were indeed gelling in the 
appropriate manner 2) Provide visual insight into the fiber network of the collagen gels 
made. 
Slide Setup 
Following the protocol described earlier, collagen gel solution of high-density 
was made. About 15µL of the collagen solution was pipetted onto the coverslips used for 
glass slides, ensuring the gel stayed round in shape. After “spotting” a coverslip with a 
drop of collagen, slips were placed onto a glass slide (collagen “spot” facing up) and then 
incubated for at least 24 hours. Once the coverslips and slides were removed from the 
incubator, the coverslip (gel side down) was flipped over onto the slide. The coverslips 
were then taped into place on the slide. Figure 1 shows this final setup.  
  
 





The following list outlines the settings used on the confocal microscope 
 Using the 20x objective, brightfield was used to locate the gel location on the 
slide 
 Emission region of 371-501 nanometers was used 
 Laser path consisted of the 800 nanometer laser with plate on top and MBS-690+ 
filter below 
 After switching to live imaging, adjusted the following properties 
o Laser intensity: Between 2-4% 
o Pinhole: Always set to the maximum 
o Master Gain: Ranged from 690-750 
o Number: Did an average of 4 scans 
o Zoom: This was only adjusted when a zoomed-in section of the 
whole/original image was desired 
 
Quantification of Images 
 Fiber formation in these images were quantified using ImageJ software. This 
process involved converting the image files to binary forms (i.e. black and white). Black 
pixel values were associated with fibers in the gel, while the white values represented the 
background. These values were then used to calculate the percent of the image area what 
was collagen positive using the formula below.   




𝑛𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑏𝑙𝑎𝑐𝑘 𝑝𝑖𝑥𝑒𝑙𝑠
𝑡𝑜𝑡𝑎𝑙 𝑛𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑝𝑖𝑥𝑒𝑙𝑠
 
Comparisons were made between gels of different concentrations and images taken at 
different locations of the gel on the slide (center vs. outer). In order to make proper 
comparisons between images, care was to taken ensure all image sizes were the same.  A 







Diffusion Experiment Setup 
 
A simple diffusion experiment was setup to measure the movement of dextrans in 
the collagen gels created.  
Determining Volume of Dextrans Needed 
Before adding dextrans to the gels, the volume of each dextran to be added to the 
collagen gel solution had to be determined. To test these various volumes,different 
volumes of each size dextran – 3kDa Texas Red, 10kDa Texas Red, 70kDa Texas Red, 
and 2M Da Tritc – to 1 mL of 10x (+/+) PBS in  a 6-well plate. Fluorescence in each well 
was then measured using the plate reader, ensuring that there was no overflow and the 
values fell within a sufficient range that could be read even when the dextrans are added 
to the collagen gels. After several experiments of using the dextrans in PBS, it was 
determined to proceed experimentation using only the 3kDa, 70kDa, and 2M Da in a ratio 
of 1:2.5:5, respectively. 
Well Plate Setup 
Collagen gels were made according to the low-density collagen protocol 
described earlier. Final collagen concentration was kept around 1.5 mg/mL (~0.27% w/v 
solution). However, before pipetting the original collagen solution into the well-plate, the 
final volume of collagen solution was separated into 3-1.5 mL tubes and an appropriate 
amount of dextran for a single tube (i.e. Tube 1 contained just the 3kDa dextran and 
collagen solution, Tube 2 contained just the 70kDa dextran and collagen solution and 
etc.) was added. Each tube was then mixed well by swirling and each dextran+collagen 
solution was added to the 12-well plate (Figure 2). The gel solution was pipetted in the 
bottom “corner” of the well and allowed to gel for 1hr at 37°C and 5% CO2. The plate 
was incubated at an angle to ensure the gels remained in the “corner”. After gelation, 
1mL of 1x (+/+) PBS was added to all 9 wells. The last row of wells, which served as the 












                   
                   
                              Figure 2: 12-well plate setup for diffusion experiments                      
 
Plate Reader Setup  
 The 12-well plate was then setup to run on the plate reader for a period of 18-21 
hours. This setup involved doing a 9x9 area scan of each well at the respective 
excitation/emission values for each dextran. Both the Texas Red dextrans had 
excitation/emission values of 595/615, while the Tritc dextran had values of 555/585. The 
fluorescence was measured in the area scans and served as a measure of the diffusion 
over time. The data collected from the plate reader was analyzed in Excel by plotting the 
standard deviations of the fluorescence values over time. Because doublets were used for 
each dextran, the average of the two readings was used when calculating the standard 
deviations. The final values for each dextran were normalized against the first reading 
and plotted as a graph.  
 
Diffusion Coefficients 
 In order to validate the outcome of the diffusion experiments, the diffusion 
coefficients of each dextran molecule were calculated and compared to literature values 
found in a previous study. Calculations were made using the following formula from 






Here 𝑘𝐵 =  the Boltzman’s constant, 𝑇 =  temperature in Kelvin, 𝜇 = viscosity of liquid 
medium and 𝑅ℎ = the hydrodynamic radius of each dextran. 
The use of this formula requires the assumption that the molecule maintains a spherical 
configuration and the viscosity used was that of PBS. Hydrodynamic radii for each 
dextran are shown in Table 2. 
Molecule Radii (nm) 
3 kDa Texas Red 1.25 [12] 
70 kDa Texas Red 5.5 [12] 
2 MDa Tritc 27 [13] 
                                   Table 2: Rh values for dextrans used 
The use of these values allowed for a reasonable expectation for the diffusion experiment 



















 Images of the collagen gels made were taken using the confocal microscope. 
Collagen fibers in the gels were most visible in the gels of concentrations 5 mg/mL and 7 
mg/mL (Figure 3 and Figure 4). Despite multiple attempts, clear images of the fibers 
could not be obtained for gels made with concentrations lower than 5 mg/mL.  The white 
portions of the image indicate the fibers present in the gel.  
     
Figure 3: Confocal images for gels of concentration 5 mg/mL with a) being an image 




     
Figure 4: Confocal images for gels of concentration 7 mg/mL a) being an image taken at 
the center of the gel and b) taken near the outer edges of the gel 
 
Quantification of Images 
 Fiber formation in the images were quantified using the method outlined 
previously. Figure 5 shows the process method for a sample image. 
                      
Figure 5: Process method for quantification of images 
 
After quantification of the images, average values of collagen positive areas were 
determined. Figure 6 demonstrates the average percent of collagen positive areas with 






Figure 6: Average collagen positive area for the two concentrations of collagen gels  
 
For each concentration of gel imaged, the percentage of collagen positive areas with 





























































Figure 7: Average collagen positive area with respect to gel location in the image a) 5 
mg/mL concentration b) 7 mg/mL concentration 
 
Diffusion Experiment 
The calculated diffusion coefficients are shown in the Table 3. As expected, the 
D0 values decreased with increasing size of molecule. 
Molecule D0 (m2/s) 
3 kDa Texas Red 1.679 * 10-10 
70 kDa Texas Red 3.817 * 10-11 
2 MDa Tritc 7.774 * 10-12 
                Table 3: Diffusion coefficient values for dextrans tested 
 These calculated values were then compared to literature values found in previous 
studies (Table 4).  This provided further support for the expected outcome in the 
diffusion experiment. These values were based on FRAP experiments conducted on 1% 

































Molecule D0 (m2/s) 
3 kDa Texas Red 3 * 10-8  
70 kDa Texas Red 7.8 * 10-9  
2 MDa Tritc 7.5 * 10-10  
                      Table 4: Literature values for diffusion coefficients [11] 
 Both these sets of values indicated that diffusion would decrease with increasing 
size of molecules. As a result, it was expected that the diffusion experiment on the 
collagen gels created would demonstrate a similar trend. Specifically, the 3kDa would 
diffuse much faster than the larger 2 MDa dextran. 
 After the diffusion experiment was conducted, standard deviation values were 
calculated from the fluorescence readings obtained from the plate reader. These values 
were then normalized for each dextran and plotted as a function of time (Fig 8).  This 
allowed for measurement of the overall distribution of the dextrans in the well. As a 
result, these normalized standard deviation values are expected to decrease over time as 
the dextrans move from being concentrated within the gel alone to being more evenly 











 The images obtained from the confocal microscope allowed for deeper 
visualization for the fiber formation in the collagen gels. Some general patterns were seen 
after analyzing these images further. 
Concentration of Gels: 
 The images shown here were from gels of concentrations 5 mg/mL and 7 mg/mL. 
This was primarily due to the fact that these gels were the easiest to image. Gain values 
did not exceed 725, required laser intensity (2-2.5%), and little background noise was 
seen in these images. Furthermore, a consistent set of property values could be used to 
image these gels, even between experiments and different batches of gels. In contrast, it 
was much more difficult to image the 3 mg/mL collagen gels. Despite multiple attempts, 
the fibers in gels of this concentration were not visible and there was a significant amount 
of noise when acquiring these images. 
Fiber Structure: 
 As the images shown indicate, the fibers in the collagen gels could be seen using 
this method of microscopy. However, a consistent pattern could not be seen in the 
structure of this fiber formation. Some of the gels contained a more “web-like” pattern 
(Fig 3a), while others had a striated pattern to their fibers (Fig 4b). Similarly, previous 
studies that have imaged collagen in tumors using this method did not appear to show a 
consistent pattern in the alignment of fibers in vivo [14,15]. 
Fiber Density and Overall Fiber Formation: 
 
 Fiber density refers to the concentration of fibers seen in a given field of view. 
With the naked eye, it appeared that this density increased with increasing concentration 
of gel. However, quantification of these images showed very little difference in percent 
of collagen positive areas between the 5 mg/mL and 7 mg/mL collagen gels (Fig 7). The 
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first set of images obtained using this method of microscopy showed fibers that appeared 
to be clustered in certain areas of the sample. However, in subsequent batches of samples, 
it could be seen that the center of the gel showed much greater fiber density. This could 
be seen visually because the images taken at the center of the gel dot were much brighter, 
irrespective of the laser intensity used (Fig 3b and Fig 4b). It appeared that the density of 
fibers decreased as field of view was moved further away from the center. However, 
quantification of the images indicated that there was were very little differences in fiber 
density between images taken at the center of the gel and those taken closer to the outer 
edges (Fig 8). Only the 7 mg/mL concentration gels appeared to show a slightly lower 
percent of collagen positive area for the images taken at the outer edges of the gel (Fig 
7b).  
Diffusion Experiment 
 This experimental setup showed that the 3kDa dextran diffused out of the 
collagen the fastest, while the 2MDa dextran took much longer to diffuse. Although the 
experiment was run for 18 hours, less than 50% of the 2MDa diffused from the gel. Due 
to the size-dependent nature of diffusion, it was expected that the smaller dextrans would 
diffuse much faster than the larger dextrans. These experimental results did indeed align 
with this expectation. Given that all other parameters were kept constant for each 
molecule and gel combination tested, the differences in diffusion coefficients explain the 
variations seen in the diffusion times for each molecule. This observation was further 
validated by the calculation of the diffusion coefficients for the dextrans and the literature 
values found in previous studies. The 3kDa had the lowest diffusion coefficient, while the 
2MDa Tritc had a much greater value (Tables 3 and 4). It should be pointed out that the 
literature values obtained were based on gels of a much greater concentration that ones 
used in this study. However, because the gels used in this study were of a much lower 
concentration, the calculated values were much lower. Overall, the relationship between 
size, diffusion time and diffusion coefficient remained the same: Diffusion coefficient 
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increased with increasing size of molecule and, thereby, resulting in slower diffusion 
times.  
 Although the diffusion experiment validated the expected outcome for the 
diffusion of dextrans through these gels, it also served as a proof-of-concept for the 
underlying purpose for the use of the collagen gels. These results corroborated the notion 
that these collagen gels do indeed allow for movement of particles through the fiber 
network. This was evident in the diffusion of the dextrans from inside the gel into the 
PBS solution surrounding the gel. Therefore, these gels can be used in further testing of 
nanoparticle drug delivery and in the future development of a microfluidic testing device 
that would contain a collagen matrix to mimic the tumor environment.  
 It is important to note that the diffusion experiment was conducted using only one 
concentration of gel, which was a concentration of 1.5 mg/mL. In order to understand the 
effects of the collagen on the movement of these particles, further testing would need to 
be conducted using higher concentrations of gels. It is expected that higher 
concentrations of gels would correspond to lower diffusion times for each molecule 
between the concentrations tested. This effect would stem primarily from the presence of 














 The primary goal of this study was to lay the groundwork for a collagen-based 
model for NP drug testing. The use of collagen gels served as the basis for this work. 
After the creation of gels, 2-photon microscopy was utilized to confirm and analyze fiber 
formation in these gels. General patterns were seen in the fiber structure and density of 
the gels created. Furthermore, this set of experiments validated the use of microscopy to 
visualize collagen gels, as opposed to traditional methods that involve the use of dyes. In 
addition, the diffusion experiment served as a proof-of-concept for future work that will 
be done using these collagen gels as a testing model for drug delivery. Because the results 
aligned with the expected diffusion patterns, this set of experiments indicated that these 
gels could be used to study how particles move through the pores, a feature that can be 
extended to what is seen in vivo in tumor tissues. 
 Future work stemming from this work will require further analysis of the collagen 
gels. For example, it will be important to the study the mechanical properties of the gels, 
including the elasticity of the collagen. This will ensure that the gels are indeed similar to 
seen to what is seen in tumors, especially because it is desirable for this model to 
simulate in vivo conditions. Extensions of the diffusion experiment will include testing 
collagen gels of varying concentrations. In addition, it will be essential to determine the 
appropriate concentration of gel to be used and use only that specific concentration for 
subsequent experimentation. Similarly, this concentration would need to be close to 
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